These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33739899)

  • 1. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.
    An HH; Li M; Liu RL; Wu J; Meng SL; Guo J; Wang ZJ; Qian SS; Shen S
    Emerg Microbes Infect; 2023 Dec; 12(1):e2147022. PubMed ID: 36373411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
    Hu G; Jin WP; Yang ZH; Lv SY; Wu J; Yu YT; Meng SL; Guo J; Wang ZJ; Shen S
    Vaccine; 2022 Aug; 40(33):4716-4725. PubMed ID: 35760737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.
    Jiang Z; Zhang Y; Lin H; Cheng Q; Lu X; Liu W; Zhou R; Zhong B; Tian X
    Front Immunol; 2021; 12():665197. PubMed ID: 34054834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice.
    Chen X; Zhang Y; Mao N; Zhu S; Ji T; Xu W
    Arch Virol; 2019 Dec; 164(12):2975-2984. PubMed ID: 31570994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an Enterovirus 71 Vaccine Efficacy Test Using Human Scavenger Receptor B2 Transgenic Mice.
    Imura A; Sudaka Y; Takashino A; Tamura K; Kobayashi K; Nagata N; Nishimura H; Mizuta K; Koike S
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
    Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
    Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease.
    Wang SH; Wang A; Liu PP; Zhang WY; Du J; Xu S; Liu GC; Zheng BS; Huan C; Zhao K; Yu XF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.